Law M R, Cheng R, Hackshaw A K, Allaway S, Hale A K
Department of Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, St Bartholomew's, London, UK.
Eur J Epidemiol. 1997 Jul;13(5):553-8. doi: 10.1023/a:1007389712487.
It is known that among women over the age of 65, bone mineral density is lower, and the risk of hip fracture higher, in smokers than non-smokers. We report a study in 1334 health pre- and post-menopausal women aged 35-64 years, to determine whether this effect can be attributed to lower oestrogen levels in smokers. Among 676 premenopausal women forearm bone density was no lower in smokers (95% confidence interval 1% lower, 4% higher). Among 543 postmenopausal women who had not used hormone replacement therapy (HRT) for more than a year there was no statistically significant difference, but the lower confidence interval was consistent with a lower bone density in older smokers (by 8% at age 55-59, 16% at age 60-64). Measurements in 194 postmenopausal women not taking HRT showed that oestrone and oestradiol were similar in smokers and non-smokers, as were cortisol and FSH, LH and prolactin. Meta-analysis of the present study and previous studies confirmed significantly higher levels in smokers of the androgens DHEAS (by 37%) and androstenedione (by 34%). Oestrogens were no lower in smokers, and the lower confidence limit excluded more than a trivial effect of smoking in lowering oestrogen. These results indicate that the recognised lower bone density in elderly smokers cannot be explained by an effect of smoking on oestrogen, since in premenopausal women bone density is no lower in smokers and in postmenopausal women oestrogens are no lower in smokers. The data suggest a balance between higher androgen levels but lower rates of conversion of androgens to oestrogens in smokers. The effect of smoking on bone may be due to impaired response of bone and other target organs to oestrogen, or to actions independent of oestrogen.
众所周知,在65岁以上的女性中,吸烟者的骨矿物质密度低于不吸烟者,髋部骨折风险高于不吸烟者。我们报告了一项针对1334名年龄在35 - 64岁之间的绝经前和绝经后健康女性的研究,以确定这种影响是否可归因于吸烟者较低的雌激素水平。在676名绝经前女性中,吸烟者的前臂骨密度并不低(95%置信区间为低1%,高4%)。在543名未使用激素替代疗法(HRT)超过一年的绝经后女性中,虽无统计学显著差异,但较低的置信区间表明老年吸烟者的骨密度较低(55 - 59岁时低8%,60 - 64岁时低16%)。对194名未服用HRT的绝经后女性的测量显示,吸烟者和不吸烟者的雌酮和雌二醇相似,皮质醇、促卵泡生成素、促黄体生成素和催乳素也相似。对本研究和以往研究的荟萃分析证实,吸烟者的雄激素硫酸脱氢表雄酮(高37%)和雄烯二酮(高34%)水平显著更高。吸烟者的雌激素水平并不低,较低的置信下限排除了吸烟对降低雌激素的显著影响。这些结果表明,老年吸烟者公认的较低骨密度不能用吸烟对雌激素的影响来解释,因为在绝经前女性中吸烟者的骨密度并不低,而在绝经后女性中吸烟者的雌激素水平也不低。数据表明吸烟者雄激素水平较高但雄激素向雌激素的转化率较低之间存在一种平衡。吸烟对骨骼的影响可能是由于骨骼和其他靶器官对雌激素的反应受损,或者是由于独立于雌激素的作用。